Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays

References

• Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667–1678.
   PubMed Web of Science ®Google Scholar
• Organization WH. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
   Google Scholar
• Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2008;117(4):e25–146.
   PubMed Web of Science ®Google Scholar
• Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943–957.
   PubMed Web of Science ®Google Scholar
• Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–2165.
   PubMed Web of Science ®Google Scholar
• Fox KA, Carruthers KF, Dunbar DR, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian study). Eur Heart J. 2010;31(22):2755–2764.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551–2567.
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
   PubMed Web of Science ®Google Scholar
• Wu AHB, Christenson RH, Greene DN et al. Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. (1530–8561 (Electronic)).
   Google Scholar
• Gluud C, Gluud LL. Evidence based diagnostics. BMJ. 2005;330(7493):724.
   PubMedGoogle Scholar
• Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ: Br Med J. 2002;324(7336):539–541.
   PubMedGoogle Scholar
• Macaskill PGC, Deeks JJ, Harbord RM, et al. Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0. The Cochrane Collaboration; 2010. Available from: https://srdta.cochrane.org/
   Google Scholar
• Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, et al. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ. 2012;344:e686-e686.
   PubMedGoogle Scholar
• Newman TB, Kohn MA. Evidence-based diagnosis. Cambridge: Cambridge University Press; 2009.
   Google Scholar
• Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet. 2000;356(9244):1844–1847.
   PubMed Web of Science ®Google Scholar
• Moons KG. Criteria for scientific evaluation of novel markers: a perspective. Clin Chem. 2010;56(4):537–541.
   PubMed Web of Science ®Google Scholar
• Hunink MG GP, Weinstein MC, Wittenberg E, et al. Decision making in health and medicine. Integrating evidence and values. Cambridge: Cambridge UniversityPress; 2001.
   Google Scholar
• Siebert U. The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease. Z Kardiol. 2002;91(Suppl 3):144–151.
   PubMedGoogle Scholar
• Siebert U. When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ. 2003;4(3):143–150.
   Google Scholar
• Trikalinos TA(1), Siebert U, Lau J. Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. Med Decis Making. 2009 Sep-Oct;29(5):E22-9. doi: 10.1177/0272989X09345022. Epub2009 Sep 4.
   Google Scholar
• CADTH Optimal use reports. In: High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health Copyright (c) 2013 Canadian Agency for Drugs and Technologies in Health; 2013.
   Google Scholar
• Goodacre S, Thokala P, Carroll C, et al. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess. 2013;17(1):v-vi, 1–188.
   Web of Science ®Google Scholar
• Tacconelli E. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis. 2010;10(4):226.
   Google Scholar
• Jj C, Ah B, Siebert U, et al. Force I-SMGRPT. Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Med Decis Making. 2012;32(5):667–677.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMC Medicine. 2013;11:80.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Jefferson TO Guidelines for authors and peer reviewers of economic submissions to the BMJ. 1996.
   Google Scholar
• Cullen L, Than M, Brown AFT, et al. Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia. Emergency Medicine Australasia: EMA. 2010;22(1):35–55.
   PubMed Web of Science ®Google Scholar
• Cullen L, Greenslade J, Merollini K, et al. Cost and outcomes of assessing patients with chest pain in an Australian emergency department. Med J Aust. 2015;202(8):427–432.
   PubMed Web of Science ®Google Scholar
• Diercks DB, Peacock W4F, Hollander JE et al. Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain. (1097–6744 (Electronic))).
   Google Scholar
• Alter DA, Ko DT, Tu JV, et al. The average lifespan of patients discharged from hospital with heart failure. J Gen Intern Med. 2012;27(9):1171–1179.
   PubMed Web of Science ®Google Scholar
• Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11(14):,1-iv.
   Web of Science ®Google Scholar
• Nilsson S, Ortoft K, Mölstad S. The accuracy of general practitioners’ clinical assessment of chest pain patients. Eur J Gen Pract. 2008;14(2):50–55.
   PubMedGoogle Scholar
• Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voorkostenonderzoek, methoden en standaardkostprijzenvooreconomischeevaluaties in de gezondheidszorg. Rotterdam: Instituutvoor Medical Technology Assessment, Erasmus Universiteit; 2010. ( Geactualiseerdeversie).
   Google Scholar
• Tarieventabel DBC zorgproducten en overige producten per 1 januari 2016. Zorgautoriteit, N. 2016.
   Google Scholar
• Poos MJJCVDI, Engelfriet PM, Deckers JW. Hoe vaak komen coronaire hartziekten voor en hoeveel mensen sterven eraan? In: Volksgezondheid Toekomst Verkenning.
   Google Scholar
• Volksgezondheidenzorg.info: Cijfertool Kosten van Ziekten. 2015.
   Google Scholar
• Zorgautoriteit N: Open data van de Nederlandse Zorgautoriteit. 2016.
   Google Scholar
• Smolina K, Wright FL, Rayner M, et al. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes. 2012;5(4):532–540.
   PubMed Web of Science ®Google Scholar
• Allen LA, O’Donnell CJ, Camargo CA Jr., et al. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J. 2006;151(5):1065–1071.
   PubMed Web of Science ®Google Scholar
• Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342(16):1163–1170.
   PubMed Web of Science ®Google Scholar
• Mills NL, Churchhouse AMD, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. Jama. 2011;305(12):1210–1216.
   PubMed Web of Science ®Google Scholar
• Selmer R, Sakshaug S, Skurtveit S, et al. Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education. Br J Clin Pharmacol. 2009;67(3):355–362.
   PubMed Web of Science ®Google Scholar
• Chhatwal J, Jayasuriya S, Elbasha EH. Changing cycle lengths in state-transition models: challenges and solutions. Med Decis Making. 2016;36:952–964.
   PubMed Web of Science ®Google Scholar
• Goodacre S, Bradburn M, Fitzgerald P, et al. The RATPAC (Randomised assessment of treatment using panel assay of cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess. 2011;15(23):iii-102.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford, United Kingdom: Oxford Medical Publications; 2015.
   Google Scholar
• Johnson PA, Goldman L, Sacks DB, et al. Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain. Am Heart J. 1999;137(6):1137–1144.
   PubMed Web of Science ®Google Scholar
• Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol. 1998;32(1):8–14.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.occp.com
   Google Scholar
• Prismant K. Financiële Statistiek 2009, Algemene ziekenhuizen Landelijke tabellen. Utrecht; 2010. p. 1–50.
   Google Scholar
• Fesmire F, Campbell M, Decker W, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. American college of emergency physicians. Ann Emerg Med. 2000;35(5):521–544.
   Web of Science ®Google Scholar
• Goodacre SW, Morris FM, Campbell S, et al. A prospective, observational study of a chest pain observation unit in a British hospital. Emerg Med J. 2002;19(2):117–121.
   PubMed Web of Science ®Google Scholar
• British National Formulary. 2016.
   Google Scholar
• Stinnett AAMM, Weinstein MC, Kuntz K, et al. The cost-effectiveness of dietary and pharmacologic therapy for cholesterol reduction in adults. In: Gold MR RL, Siegel JE, Weinstein MCeditors. Cost-effectiveness in health and medicine. New York: Oxford UnivPr; 1996. p. 349–391.
   Google Scholar
• Thokala P, Goodacre SW, Collinson PO, et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart. 2012;98(20):1498–1503.
   PubMed Web of Science ®Google Scholar
• Collinson PO, Gaze DC, Thokala P, et al. Randomised assessment of treatment using panel assay of cardiac markers–contemporary biomarker evaluation (RATPAC CBE). Health Technol Assess. 2013;17(15):v-vi, 1–122.
   Google Scholar
• Polanczyk CA, Kuntz KM, Sacks DB, et al. Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: a cost-effectiveness analysis. Ann Intern Med. 1999;131(12):909–918.
   PubMed Web of Science ®Google Scholar
• Kip MMA. Decreasing time to diagnosis in patients with acute chest pain: the incremental cost-effectiveness of implementing a multiple biomarker assay for early exclusion of NSTEMI. [master’s thesis]. University of Twente School of Management and Governance; 2012.
   Google Scholar
• Julicher P, Greenslade JH, Parsonage WA, et al. The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis. BMJ Open. 2017;7(6):e013653.
   PubMed Web of Science ®Google Scholar
• Goodacre S, Calvert N. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain. Emerg Med J. 2003;20(5):429–433.
   PubMed Web of Science ®Google Scholar
• Vaidya A, Severens J, Bongaerts B, et al. High-sensitive Troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BMC Cardiovasc Disord. 2014;14(1):77.
   PubMedGoogle Scholar
• Kip MMA, Koffijberg H, Moesker MJ, et al. The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care. BMC Cardiovasc Disord. 2017;17(1):213.
   PubMedGoogle Scholar
• Westwood M, van Asselt T, Ramaekers B, et al. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(44):1–234.
   Web of Science ®Google Scholar
• Smith MD, Drummond M, Brixner D. Moving the QALY forward: rationale for change. Value Health. 2009;12(Suppl 1):S1–4.
   PubMedGoogle Scholar
• Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling good research practices task force–6. Value Health. 2012;15(6):835–842.
   PubMed Web of Science ®Google Scholar
• Eddy DM, Hollingworth W, Caro JJ, et al. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force–7. Value Health. 2012;15(6):843–850.
   PubMed Web of Science ®Google Scholar
• Jaime Caro J, Eddy DM, Kan H, et al. Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health. 2014;17(2):174–182.
   PubMed Web of Science ®Google Scholar
• Rogowski W, Payne K, Schnell-Inderst P, et al. Concepts of ‘personalization’ in personalized medicine: implications for economic evaluation. Pharmacoeconomics. 2015;33(1):49–59.
   PubMed Web of Science ®Google Scholar
• Kind PHG, Macran S UK population norms for EQ-5D. 1999.
   Google Scholar
• Goodacre S, Mason S, Arnold J, et al. Psychologic morbidity and health-related quality of life of patients assessed in a chest pain observation unit. Ann Emerg Med. 2001;38(4):369–376.
   PubMed Web of Science ®Google Scholar
• Weinstein MC, O’Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices–modeling studies. Value Health. 2003;6(1):9–17.
   PubMed Web of Science ®Google Scholar
• Siebert U, Rochau U, Claxton K. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Z Evid Fortbild Qual Gesundhwes. 2013;107(9–10):575–584.
   PubMedGoogle Scholar
• Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Med Decis Making. 2012;32(5):690–700.
   PubMed Web of Science ®Google Scholar
• Karnon J, Stahl J, Brennan A, et al. Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4. Med Decis Making. 2012;32(5):701–711.
   PubMed Web of Science ®Google Scholar
• Laking G, Lord J, Fischer A. The economics of diagnosis. Health Econ. 2006;15(10):1109–1120.
   PubMed Web of Science ®Google Scholar
• Sanghera S, Orlando R, Roberts T. Economic evaluations and diagnostic testing: an illustrative case study approach. Int J Technol Assess Health Care. 2013;29(1):53–60.
   PubMed Web of Science ®Google Scholar
• Sutton AJ, Cooper NJ, Goodacre S, et al. Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests. Med Decis Making. 2008;28(5):650–667.
   PubMed Web of Science ®Google Scholar
• Paul M, Riebler A, Bachmann LM, et al. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations. Stat Med. 2010;29(12):1325–1339.
   PubMed Web of Science ®Google Scholar
• Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–691.
   PubMed Web of Science ®Google Scholar
• Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012;59(23):2091–2098.
   PubMed Web of Science ®Google Scholar
• Homer JB, Hirsch GB. System dynamics modeling for public health: background and opportunities. Am J Public Health. 2006;96(3):452–458.
   PubMed Web of Science ®Google Scholar
• Lattimer V, Brailsford S, Turnbull J, et al. Reviewing emergency care systems I: insights from system dynamics modelling. Emerg Med J. 2004;21(6):685–691.
   PubMed Web of Science ®Google Scholar
• Doble B, Tan M, Harris A, et al. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist. Expert Rev Mol Diagn. 2015;15(2):235–254.
   PubMed Web of Science ®Google Scholar
• Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2. Med Decis Making. 2012;32(5):678–689.
   PubMed Web of Science ®Google Scholar
• Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health. 2013;16(6 Suppl):S20–26.
   PubMed Web of Science ®Google Scholar
• Grosse SD, Wordsworth S, Payne K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med. 2008;10(9):648–654.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Garber AM. Individualized cost-effectiveness analysis. PLoS Med. 2011;8(7):e1001058.
   PubMed Web of Science ®Google Scholar
• Zaric GS. Cost implications of value-based pricing for companion diagnostic tests in precision medicine. Pharmacoeconomics. 2016;34(7):635–644.
   PubMed Web of Science ®Google Scholar
• Coyle D, Buxton MJ, O’Brien BJ. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12(5):421–427.
   PubMed Web of Science ®Google Scholar
• Basu A, Meltzer D. Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2):112–127.
   PubMed Web of Science ®Google Scholar
• Espinoza MA, Manca A, Claxton K, et al. The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34(8):951–964.
   PubMed Web of Science ®Google Scholar
• Biesheuvel C, Irwig L, Bossuyt P. Observed differences in diagnostic test accuracy between patient subgroups: is it real or due to reference standard misclassification? Clin Chem. 2007;53(10):1725–1729.
   PubMed Web of Science ®Google Scholar
• Chahal K, Eldabi T. Hybrid simulation and modes of governance in UK healthcare. Transforming Government: People, Process and Policy. 2011;5(2):143–154.
   Google Scholar
• Damman P, van ‘T Hof AW, Ten Berg JM, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group. Neth Heart J. 2016.
   Web of Science ®Google Scholar